Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma

Clinical trial NCT07150715 · RECRUITING

Trial details

NCT number: NCT07150715
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oligometastatic Prostate Adenocarcinoma Recurrent Prostate Adenocarcinoma

Start date: 2025-12-12
Primary completion: 2030-10-31
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.